Korea Biomedical Review

Korea Biomedical Review[3] (traditional Chinese: 韓國生物醫學評論[4]; simplified Chinese: 韩国生物医学评论[5]; pinyin: Hánguó shēngwù yīxué pínglùn), abbreviated as KBR, [6] is a South Korea-based[7] online English-language newspaper that mainly delivers news related to the field of healthcare in the Republic of Korea.[8]

Korea Biomedical Review
韩国生物医学评论
FormatOnline[1]
FoundedFebruary 22, 2017
LanguageEnglish
HeadquartersSeoul, Korea
Sister newspapersKorean Doctors' Weekly
Websitekoreabiomed.com[2]

Korea Biomedical Review is the first English newspaper in South Korea focusing on the healthcare field, [9] and its ISO 4 abbreviation is Korea Biomed. Rev..[10]

The newspaper's official website domain name, koreabiomed.com, [11] was registered on October 7, 2016.[12] The first issue of Korea Biomedical Review was released on 22 February 2017 as a sister paper to its Korean version, the Korean Doctors' Weekly.[13]

References
  1. Sabrina Ching Yuen Luk (6 January 2020). Ageing, Long-term Care Insurance and Healthcare Finance in Asia. Routledge. pp. 2023–. ISBN 978-1-351-63134-1.
  2. OECD (31 March 2020). OECD Reviews of Public Health: Korea A Healthier Tomorrow: A Healthier Tomorrow. OECD Publishing. pp. 130–. ISBN 978-92-64-68964-0.
  3. "Korean professors indicted in admissions case tied to politics". Times Higher Education. Jan 3, 2020.
  4. "【韓國疫情．武漢肺炎】超級傳播者引爆疫情　MERS惡夢再臨？". HK01. 2020-02-22.
  5. "香港佛堂 韩国教会各爆疫情 两地政府应叫停聚众宗教活动". Sing Pao Daily News. 2020-02-24.
  6. "[South Korean medical scandal] It is reported that more than 100 doctors have been involved in receiving rebates from pharmaceutical factories, with a total amount of nearly 30 million Hong Kong dollars". Ming Pao. 2018-10-10.
  7. Simone Gold, M.D., J.D. (15 October 2020). I Do Not Consent: My Fight Against Medical Cancel Culture. Bombardier Books. pp. 57–. ISBN 978-1-64293-891-3.CS1 maint: multiple names: authors list (link)
  8. "Will a World Directory's Delisting Of Chinese Medicine Schools Affect TCM's Status?". Beijing Review. 2019-11-29.
  9. "[Congratulatory message] President of KDA Choi Nam-sup". koreabiomed.com. 2017-02-24.
  10. Tsutomu Takeuchi."Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan". Arthritis Research & Therapy. 12 March 2020.
  11. Larry D. Purnell; Eric A. Fenkl (5 September 2020). Textbook for Transcultural Health Care: A Population Approach: Cultural Competence Concepts in Nursing Care. Springer Nature. pp. 610–. ISBN 978-3-030-51399-3.
  12. "KoreAbiomed.com WHOIS, DNS, & Domain Info – DomainTools". WHOIS. Retrieved October 24, 2020.
  13. Lee Kyung-min (Mar 19, 2017). "Sunlight is the best disinfectant - The Korea Times". The Korea Times.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.